Plain-English translation of NCT06249308 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Researchers are developing a new type of blood test — called a liquid biopsy — that could detect ovarian cancer much earlier than current methods. The test uses artificial intelligence to analyze tiny pieces of cancer DNA in your blood. This study collects blood samples from patients with newly diagnosed ovarian cancer to train and test this new detection method.
Ovarian cancer is often detected late, when it's harder to treat. This trial aims to create a simple blood test that could catch ovarian cancer in its early stages, when treatment is more likely to be successful.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a single blood sample drawn, similar to a routine blood test. The researchers will analyze this blood sample to identify cancer-specific signals and help develop the new detection test. There are no ongoing visits or long-term commitments — participation involves primarily this one blood draw at the time of your ovarian cancer diagnosis.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
China